Organon BioSciences Overview
- Year Founded
-
1923
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
3
Organon BioSciences General Information
Description
Manufacturer of pharmaceutical products. The company develops, manufactures and markets products targeting selected therapeutic areas in human pharmaceuticals and covering a wide range of species in animal health. It offers its products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care and neuroscience, immunology, animal health and oncology.
Contact Information
Corporate Office
- Molenstraat 110
- 5342 CC Oss
- Netherlands
Corporate Office
- Molenstraat 110
- 5342 CC Oss
- Netherlands
Organon BioSciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Organon BioSciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Organon BioSciences Patents
Organon BioSciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4728499-A2 | Reusable surgical training applicator for subdermal implants | Pending | 16-Jun-2023 | ||
| WO-2024259291-A2 | Reusable surgical training applicator for subdermal implants | Inactive | 16-Jun-2023 | ||
| WO-2024259291-A3 | Reusable surgical training applicator for subdermal implants | Inactive | 16-Jun-2023 | ||
| WO-2012106995-A1 | Rorgammat inhibitors | Inactive | 11-Feb-2011 | ||
| WO-2012052395-A1 | Isoxazole derivatives used as oestrogen modulators | Inactive | 18-Oct-2010 | C07D261/08 |
Organon BioSciences Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Organon BioSciences Investments & Acquisitions (3)
Organon BioSciences’s most recent deal was a Corporate Asset Purchase with Johnson & Johnson (Certain Assets in Pakistan). The deal was made on 13-Sep-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Johnson & Johnson (Certain Assets in Pakistan) | 13-Sep-2013 | Corporate Asset Purchase | Buildings and Property | ||
| Searle Pakistan | 17-Apr-2008 | Merger/Acquisition | Pharmaceuticals | ||
| Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) | 26-Jun-2007 | Corporate Asset Purchase | Buildings and Property |
Organon BioSciences Exits (1)
Organon BioSciences’s most recent exit was on 17-Apr-2008 from Searle Pakistan. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Searle Pakistan | 17-Apr-2008 | Completed |
|
Organon BioSciences FAQs
-
When was Organon BioSciences founded?
Organon BioSciences was founded in 1923.
-
Where is Organon BioSciences headquartered?
Organon BioSciences is headquartered in Oss, Netherlands.
-
What industry is Organon BioSciences in?
Organon BioSciences’s primary industry is Pharmaceuticals.
-
Is Organon BioSciences a private or public company?
Organon BioSciences is a Private company.
-
What is the current valuation of Organon BioSciences?
The current valuation of Organon BioSciences is .
-
What is Organon BioSciences’s current revenue?
The current revenue for Organon BioSciences is .
-
Who are Organon BioSciences’s investors?
AkzoNobel has invested in Organon BioSciences.
-
When was Organon BioSciences acquired?
Organon BioSciences was acquired on 19-Nov-2007.
-
Who acquired Organon BioSciences?
Organon BioSciences was acquired by Schering-Plough.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
